HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,090,051 | +16.0% | 36,732 | -10.2% | 0.43% | -1.6% |
| Q2 2022 | $1,801,000 | +17.8% | 40,923 | +11.6% | 0.44% | +91.3% |
| Q1 2021 | $1,529,000 | +7.3% | 36,678 | +10.0% | 0.23% | -1.3% |
| Q4 2020 | $1,425,000 | -0.4% | 33,357 | -38.7% | 0.23% | -31.3% |
| Q3 2020 | $1,431,000 | -37.3% | 54,452 | -36.0% | 0.34% | -32.9% |
| Q2 2020 | $2,283,000 | -36.4% | 85,144 | -46.4% | 0.50% | +20.2% |
| Q2 2015 | $3,589,000 | +12.0% | 158,947 | -29.2% | 0.42% | +13.5% |
| Q1 2015 | $3,204,000 | – | 224,384 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |